Codexis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Codexis and other ETFs, options, and stocks.About CDXS
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments.
CEOStephen George Dilly
CEOStephen George Dilly
Employees188
Employees188
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2002
Founded2002
Employees188
Employees188
CDXS Key Statistics
Market cap228.65M
Market cap228.65M
Price-Earnings ratio-2.80
Price-Earnings ratio-2.80
Dividend yield—
Dividend yield—
Average volume1.14M
Average volume1.14M
High today$2.91
High today$2.91
Low today$2.69
Low today$2.69
Open price$2.84
Open price$2.84
Volume1.47M
Volume1.47M
52 Week high$6.08
52 Week high$6.08
52 Week low$1.90
52 Week low$1.90
CDXS News
Simply Wall St 16h
What You Can Learn From Codexis, Inc.'s P/SWhen you see that almost half of the companies in the Life Sciences industry in the United States have price-to-sales ratios (or "P/S") below 3x, Codexis, Inc....
TipRanks 2d
Major Shareholder Makes Bold Move with Codexis Stock PurchaseNew insider activity at Codexis ( (CDXS) ) has taken place on July 1, 2025. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50% off!...
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
28.6%
Sell
0%
People also own
Based on the portfolios of people who own CDXS. This list is generated using Robinhood data, and it’s not a recommendation.